The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.51338/rppsm.439 |
Resumo: | Introduction: Our objective was to analyze depressive symptoms during the COVID‐19 pandemic and their association with health and sociodemographic factors. Methods: A survey of 4203 adults from ten municipalities was conducted in Mato Grosso state, Amazon region of Brazil. Data collection was done at home, with the collection of sociodemographic characteristics, and aspects of both physical and mental health. The DSM‐5 level 1 cross‐sectional symptom scale was used to identify symptoms of depression, substance use disorders, sleep disturbances, and anxiety. Chemiluminescence was also used to detect IgG anti‐SARS‐CoV‐2 antibodies. Results: The estimated prevalence of anti‐SARS‐CoV‐2 antibodies was 12.5% and the prevalence of depressive symptoms was 23.2%. In the multivariate analysis, depression was associated with being male, having a low income, the level of physical activity before the pandemic, chronic illness, substance use disorder, sleep and anxiety disorders. Conclusion: Evidence on depression and its associated factors is critical to understanding the extent of the population situation from which recommendations can be made to guide public policy. |
id |
RCAP_76e089521fa6aa071998aea160f88256 |
---|---|
oai_identifier_str |
oai:ojs.www.revistapsiquiatria.pt:article/439 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional StudyFatores Sociodemográficos e de Saúde Associados aos Sintomas Depressivos Durante a Pandemia de COVID‐19: Um Estudo TransversalMental healthDepressionSARS-CoV-2Surveys and QuestionnairesSaúde mentalDepressãoSARS-CoV-2BrasilInquéritos e QuestionáriosIntroduction: Our objective was to analyze depressive symptoms during the COVID‐19 pandemic and their association with health and sociodemographic factors. Methods: A survey of 4203 adults from ten municipalities was conducted in Mato Grosso state, Amazon region of Brazil. Data collection was done at home, with the collection of sociodemographic characteristics, and aspects of both physical and mental health. The DSM‐5 level 1 cross‐sectional symptom scale was used to identify symptoms of depression, substance use disorders, sleep disturbances, and anxiety. Chemiluminescence was also used to detect IgG anti‐SARS‐CoV‐2 antibodies. Results: The estimated prevalence of anti‐SARS‐CoV‐2 antibodies was 12.5% and the prevalence of depressive symptoms was 23.2%. In the multivariate analysis, depression was associated with being male, having a low income, the level of physical activity before the pandemic, chronic illness, substance use disorder, sleep and anxiety disorders. Conclusion: Evidence on depression and its associated factors is critical to understanding the extent of the population situation from which recommendations can be made to guide public policy.Introdução: O nosso objetivo foi analisar a associação entre sintomas depressivos e fatores sociodemográficos e de saúde durante a pandemia de COVID‐19. Métodos: Foi realizado um estudo com 4203 adultos de dez municípios do estado de Mato Grosso, região amazônica do Brasil. A recolha de dados foi realizada na residência, com levantamento de informações sobre as características sociodemográficas, aspectos de saúde física e mental. A Escala de Sintomas Transversais de Nível 1 do DSM‐5 foi utilizada para identificar sintomas de depressão, transtorno por uso de substâncias, distúrbios do sono e ansiedade. A quimiluminescência foi utilizada para detectar anticorpos IgG anti‐SARS‐CoV‐2. Resultados: A prevalência estimada de anticorpos anti‐SARS‐CoV‐2 foi de 12,5% e a prevalência de sintomas depressivos foi de 23,2%. Na análise multivariada, a depressão esteve associada a ser do sexo masculino, ter baixa renda, nível de atividade física antes da pandemia, ter doença crónica, apresentar transtorno por uso de substâncias, transtornos do sono e de ansiedade. Conclusão: Os achados sobre a depressão e seus fatores associados são essenciais para a compreensão sobre a magnitude do quadro desses sintomas na população, a partir de onde podem ser feitas recomendações que norteiem as políticas públicas.Sociedade Portuguesa de Psiquiatria e Saúde Mental2023-06-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.51338/rppsm.439https://doi.org/10.51338/rppsm.439Revista Portuguesa de Psiquiatria e Saúde Mental; Vol. 9 No. 2 (2023); 36-48Revista Portuguesa de Psiquiatria e Saúde Mental; Vol. 9 N.º 2 (2023); 36-482184-54172184-5522reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.revistapsiquiatria.pt/index.php/sppsm/article/view/439https://www.revistapsiquiatria.pt/index.php/sppsm/article/view/439/142Direitos de Autor (c) 2021 Revista Portuguesa de Psiquiatria e Saúde Mentalinfo:eu-repo/semantics/openAccessTerças Trettel, Ana Cláudia PereiraMuraro, Ana PaulaNascimento, Vagner Ferreira doAndrade, Amanda Cristina de SouzaEspinosa, Mariano MartinezOliveira, Elaine Cristina deWagstaff, ChristopherPillon, Sandra Cristina2023-07-05T12:15:25Zoai:ojs.www.revistapsiquiatria.pt:article/439Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:02:21.289723Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study Fatores Sociodemográficos e de Saúde Associados aos Sintomas Depressivos Durante a Pandemia de COVID‐19: Um Estudo Transversal |
title |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
spellingShingle |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study Terças Trettel, Ana Cláudia Pereira Mental health Depression SARS-CoV-2 Surveys and Questionnaires Saúde mental Depressão SARS-CoV-2 Brasil Inquéritos e Questionários |
title_short |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
title_full |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
title_fullStr |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
title_full_unstemmed |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
title_sort |
The Health and Socio‐Demographic Factors Associated with Depressive Symptoms During the COVID‐19 Pandemic: A Cross‐Sectional Study |
author |
Terças Trettel, Ana Cláudia Pereira |
author_facet |
Terças Trettel, Ana Cláudia Pereira Muraro, Ana Paula Nascimento, Vagner Ferreira do Andrade, Amanda Cristina de Souza Espinosa, Mariano Martinez Oliveira, Elaine Cristina de Wagstaff, Christopher Pillon, Sandra Cristina |
author_role |
author |
author2 |
Muraro, Ana Paula Nascimento, Vagner Ferreira do Andrade, Amanda Cristina de Souza Espinosa, Mariano Martinez Oliveira, Elaine Cristina de Wagstaff, Christopher Pillon, Sandra Cristina |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Terças Trettel, Ana Cláudia Pereira Muraro, Ana Paula Nascimento, Vagner Ferreira do Andrade, Amanda Cristina de Souza Espinosa, Mariano Martinez Oliveira, Elaine Cristina de Wagstaff, Christopher Pillon, Sandra Cristina |
dc.subject.por.fl_str_mv |
Mental health Depression SARS-CoV-2 Surveys and Questionnaires Saúde mental Depressão SARS-CoV-2 Brasil Inquéritos e Questionários |
topic |
Mental health Depression SARS-CoV-2 Surveys and Questionnaires Saúde mental Depressão SARS-CoV-2 Brasil Inquéritos e Questionários |
description |
Introduction: Our objective was to analyze depressive symptoms during the COVID‐19 pandemic and their association with health and sociodemographic factors. Methods: A survey of 4203 adults from ten municipalities was conducted in Mato Grosso state, Amazon region of Brazil. Data collection was done at home, with the collection of sociodemographic characteristics, and aspects of both physical and mental health. The DSM‐5 level 1 cross‐sectional symptom scale was used to identify symptoms of depression, substance use disorders, sleep disturbances, and anxiety. Chemiluminescence was also used to detect IgG anti‐SARS‐CoV‐2 antibodies. Results: The estimated prevalence of anti‐SARS‐CoV‐2 antibodies was 12.5% and the prevalence of depressive symptoms was 23.2%. In the multivariate analysis, depression was associated with being male, having a low income, the level of physical activity before the pandemic, chronic illness, substance use disorder, sleep and anxiety disorders. Conclusion: Evidence on depression and its associated factors is critical to understanding the extent of the population situation from which recommendations can be made to guide public policy. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06-07 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.51338/rppsm.439 https://doi.org/10.51338/rppsm.439 |
url |
https://doi.org/10.51338/rppsm.439 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistapsiquiatria.pt/index.php/sppsm/article/view/439 https://www.revistapsiquiatria.pt/index.php/sppsm/article/view/439/142 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2021 Revista Portuguesa de Psiquiatria e Saúde Mental info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2021 Revista Portuguesa de Psiquiatria e Saúde Mental |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Psiquiatria e Saúde Mental |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Psiquiatria e Saúde Mental |
dc.source.none.fl_str_mv |
Revista Portuguesa de Psiquiatria e Saúde Mental; Vol. 9 No. 2 (2023); 36-48 Revista Portuguesa de Psiquiatria e Saúde Mental; Vol. 9 N.º 2 (2023); 36-48 2184-5417 2184-5522 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131690063364096 |